Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method
- PMID: 21158319
- PMCID: PMC2994933
- DOI: 10.1118/1.3495817
Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method
Abstract
Purpose: The traditional figures of merit used in the evaluation of positron emission tomography (PET) systems, including system sensitivity and spatial resolution, do not directly reflect the minimum detectable activity (MDA) performance, despite the fact that it is one of the most important tasks for a PET system. MDA, as a combination of the more traditional PET system parameters, is directly related to lesion detection. However, MDA evaluation is task specific and cannot be done by a single measurement. Therefore, a simple method to evaluate system detectability needs to be developed.
Methods: In this work, an analytical method of MDA estimation was developed, taking into account system sensitivity, spatial resolution, source properties, and noise propagation in image reconstruction by using the Rose criterion and/or the Curie equation as the detection standard. In the implementation, the source background, as well as the intrinsic activity background from the scintillation material of the system, was also taken into consideration. The accuracy of this method was evaluated in two commercially available preclinical PET systems, with phantom experiments that were designed to closely mimic in vivo tumor uptake without introducing finite boundaries between the source and the background.
Results: The lesion contrast-to-noise ratio calculated by the analytical evaluation showed good agreement with that obtained from the experiments. Visual assessment of the reconstructed images at the detection limit (based on analytical evaluation) also was in agreement with the Rose criterion. The MDA performance was quantitatively compared between the two preclinical PET systems and showed different detection limits under different imaging conditions, suggesting that the detection limit of a PET system strongly depends on the lesion properties and acquisition settings.
Conclusions: An analytical method of evaluating the PET system detectability was developed and validated by experiments. Overall, the analytical MDA calculation provides a simple way to evaluate the signal detectability of a PET system and can be used for comparing different systems. It also provides guidelines for designing new PET tomographs as well as optimizing data acquisition protocols.
Figures






Similar articles
-
Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.Invest Radiol. 2013 May;48(5):290-4. doi: 10.1097/RLI.0b013e3182823695. Invest Radiol. 2013. PMID: 23399811
-
Physical performance of the new hybrid PET∕CT Discovery-690.Med Phys. 2011 Oct;38(10):5394-411. doi: 10.1118/1.3635220. Med Phys. 2011. PMID: 21992359
-
Phantom and methodology for comparison of small lesion detectability in PET.Med Phys. 2023 May;50(5):2998-3007. doi: 10.1002/mp.16187. Epub 2023 Jan 11. Med Phys. 2023. PMID: 36576853 Free PMC article.
-
Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging.Mol Imaging Biol. 2015 Oct;17(5):704-13. doi: 10.1007/s11307-015-0824-x. Mol Imaging Biol. 2015. PMID: 25634260 Free PMC article.
-
Advances in Preclinical PET.Semin Nucl Med. 2022 May;52(3):382-402. doi: 10.1053/j.semnuclmed.2022.02.002. Epub 2022 Mar 18. Semin Nucl Med. 2022. PMID: 35307164 Free PMC article. Review.
Cited by
-
Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury.Nat Commun. 2023 Jan 13;14(1):197. doi: 10.1038/s41467-023-35868-8. Nat Commun. 2023. PMID: 36639379 Free PMC article.
-
Modeling contrast-to-noise ratio from list mode reconstructions of 68Ga DOTATATE PET/CT: predicting detectability of hepatic metastases in shorter acquisition PET reconstructions.Am J Nucl Med Mol Imaging. 2023 Feb 15;13(1):33-42. eCollection 2023. Am J Nucl Med Mol Imaging. 2023. PMID: 36923602 Free PMC article.
-
Multifunctional-layered materials for creating membrane-restricted nanodomains and nanoscale imaging.Appl Phys Lett. 2016 Jan 18;108(3):033702. doi: 10.1063/1.4940388. Epub 2016 Jan 21. Appl Phys Lett. 2016. PMID: 26869725 Free PMC article.
-
Investigation on the performance of dedicated radiotherapy positioning devices for MR scanning for prostate planning.J Appl Clin Med Phys. 2015 Mar 8;16(2):4848. doi: 10.1120/jacmp.v16i2.4848. J Appl Clin Med Phys. 2015. PMID: 26103166 Free PMC article.
-
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT.EJNMMI Res. 2013 Feb 17;3(1):11. doi: 10.1186/2191-219X-3-11. EJNMMI Res. 2013. PMID: 23414629 Free PMC article.
References
-
- Tornai M. P., Jaszczak R. J., Turkington T. G., and Coleman R. E., “Small-animal PET: Advent of a new era of PET research,” J. Nucl. Med. JNMEAQ 40, 1176–1179 (1999). - PubMed
-
- Cherry S. R. and Gambhir S. S., “Use of positron emission tomography in animal research,” ILAR J. IJLOAC 42, 219–232 (2001). - PubMed
-
- Adonai N., Nguyen K. N., Walsh J., Iyer M., Toyokuni T., Phelps M. E., McCarthy T., McCarthy D. W., and Gambhir S. S., “Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography,” Proc. Natl. Acad. Sci. U.S.A. PNASA6 99, 3030–3035 (2002).10.1073/pnas.052709599 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources